SG

Sambit Ghosh

Active Director Director DIN 08854705
DIN 08854705 First appointment Aug 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 4 historical roles
Total affiliations 7 Since Aug 2020
Shareholding value •••• Premium profile

About Sambit Ghosh

Data last updated:

Sambit Ghosh is a Director at Healthledger Private Limited (since 2022), Director at Healthledger Diagnostics Private Limited (since 2025) and Designated Partner at Realtrial Ventures Llp (since 2020). The companies operate in Healthcare, Information Technology and Internet. The 2 current companies with reported revenue have a combined latest revenue of ₹64.11 Cr; the largest is Healthledger Private Limited at ₹47.32 Cr (FY 2025). Earlier, Sambit Ghosh was a Director at Plexus Global Healthnetwork Private Limited (2022–2024) and Director at Smartqr Technologies Private Limited (2023–2024) and 2 more.

DIN 08854705
Primary Designation Director
Industry Healthcare
First Appointment 29 Aug 2020
Oldest Company Age 6 yrs
Largest company Healthledger Private Limited · ₹47.32 Cr (FY 2025)
Combined revenue ₹64.11 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Healthledger Private Limited U85100PN2022PTC207439
Director05 Jan 20222022₹47.32 Cr (FY 2025)Active
Director17 Mar 20252022₹16.78 Cr (FY 2025)Active
Designated Partner29 Aug 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Jan 20222022₹13.26 Cr (FY 2025)Active
Smartqr Technologies Private Limited U46596MH2023PTC402853
Director12 May 20232023₹16.77 Cr (FY 2025)Active
Designated Partner12 Jul 20212020Converted To Cmp And Dissolved
Designated Partner12 Jul 20212020Converted To Cmp And Dissolved

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Realtrial Ventures Llp
Plexus Global Healthnetwork Llp
Healthledger Diagnostics Llp
Healthledger Private Limited
Premium access

Shareholding and investment profile for Sambit Ghosh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sambit Ghosh

Sambit Ghosh currently holds 3 directorships: Healthledger Private Limited (Director, since 05 Jan 2022, revenue ₹47.32 Cr (FY 2025)); Healthledger Diagnostics Private Limited (Director, since 17 Mar 2025, revenue ₹16.78 Cr (FY 2025)); Realtrial Ventures Llp (Designated Partner, since 29 Aug 2020).

Sambit Ghosh was first appointed on 29 Aug 2020 as Designated Partner at Realtrial Ventures Llp. The most recent appointment on record is 17 Mar 2025 at Healthledger Diagnostics Private Limited.

The 2 current companies of Sambit Ghosh that report revenue have a combined latest revenue of ₹64.11 Cr: Healthledger Private Limited ₹47.32 Cr (FY 2025); Healthledger Diagnostics Private Limited ₹16.78 Cr (FY 2025).

Sambit Ghosh held 4 earlier board appointments: Plexus Global Healthnetwork Private Limited (Director, 11 Jan 2022 to 04 Nov 2024); Smartqr Technologies Private Limited (Director, 12 May 2023 to 04 Nov 2024); Plexus Global Healthnetwork Llp (Designated Partner, from 12 Jul 2021); Healthledger Diagnostics Llp (Designated Partner, from 12 Jul 2021).

The current boards of Sambit Ghosh's companies include Anuj Dwarkadas Mantri (Healthledger Private Limited), Rohit Vinodkumar Bajaj (Healthledger Private Limited), Neha Ambar Ayade (Realtrial Ventures Llp), Pawan Chandak Onkardas (Realtrial Ventures Llp), Viren Rajendra Bihani (Realtrial Ventures Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available